Identification and validation the predictive biomarkers based on risk-adjusted control chart in gemcitabine with or without erlotinib for pancreatic cancer therapy

ABSTRACT:

SUBMITTER: Zhao A 

PROVIDER: S-EPMC11685217 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature